#ASPN

@aspneph.bsky.social

1 week ago

The Bean Pod - Episode 2:  Pearls in the management of steroid resistant nephrotic syndrome - American Society of Pediatric Nephrology (ASPN) In this episode, Dr. Jason Misurac and Dr. Amirtha Chinnadurai are joined by Dr. Michael Somers, Professor of Pediatrics at Harvard Medical School and pediatric nephrologist at Boston Children’s…

Episode 2 of The Bean Pod is live 🎙️

Pearls in managing Steroid-Resistant Nephrotic Syndrome with Drs. Jason Misurac & Amirtha Chinnadurai, joined by Dr. Michael Somers.

Listen here: buff.ly/OZwJQBe
#PedsNeph #Nephrology #SRNS #GlomerularDisease #ASPN

@dr-curtin.bsky.social

1 month ago

A study that showed a 19 year delay from onset to treatment

At the #ASPN meeting. This was a slide highlighting how far we need to go to improve care of people with occipital nerve compression and head pain. 19 years to wait for treatment is crazy and still too often people are never offered surgery #migraine

@aspneph.bsky.social

3 months ago

All recordings are LIVE! The ASPN Pediatric Nephrology Board Review Course is now available on-demand.
Your pace. Your schedule. Your board prep. buff.ly/mcfs7PK
🔗 #ASPN #PediatricNephrology #BoardPrep

Small Cap Strategist

@smcapstrategist.bsky.social

4 months ago

Most searched small-cap stocks, Tue Nov 11th - #MTC #HIVE #ECX #QNRX #REAL #CYCU #RXRX #IOVA #TURB #BTBT #NVTS #DNN #ENGN #BITF #BBAI #PLUG #USAR #ONDS #CROX #ASPN - More: crystalequityresearch.com/most-searche... - #smallcap

StockTitan

@stocktitan.net

4 months ago

Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results and Recent Business Highlights Aspen Aerogels (NYSE: ASPN) reported Q3 2025 revenue of $73.0M and a net loss of $6.3M on Nov 6, 2025. Revenue fell from $117.3M in Q3 2024; adjusted EBITDA was $6.3M. The company updated full‑year 2025 guidance to $270–280M revenue and adjusted EBITDA of $7–15M, citing lower near‑term U.S. EV production.Key items: PyroThin award from a major European OEM with production start targeted in 2027, $152.4M cash, $15M operating cash flow, and a $287.6M impairment charge reflected in outlook.

#ASPN Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results and Recent Business Highlights

www.stocktitan.net/news/ASPN/aspen-aerogels...

@aspneph.bsky.social

6 months ago

New from ASPN!
🎙️ The Bean Pod — a short-form pediatric nephrology podcast created by the Clinical Affairs Committee.

Ep. 1: Prenatal consults in CAKUT with Dr. Keia Sanderson. Practical pearls in <20 min!

🔗 Listen now: buff.ly/GD7VK9R
#PedsNeph #ASPN #MedEd

Option Mike

@optionmike.bsky.social

7 months ago

Good Morning!

Futures flat, Bitcoin raging!

#DASH pt raised $265 from $250 @ Jefferies

#ALL pt raised $265 from $254 @ Jefferies

#DOCS pt raised $69 from $65 @ Piper

#ABNB pt cut $160 from $165 @ Jefferies

#ASPN d/g Underweight @ Barclays pt $6

StockTitan

@stocktitan.net

7 months ago

Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights Aspen Aerogels (NYSE:ASPN) reported Q2 2025 financial results with revenue of $78.0 million, down from $117.8 million in Q2 2024. The company posted a net loss of $9.1 million ($0.11 per share), which included $5.9 million in restructuring charges. Adjusted EBITDA was $9.7 million, showing a 98% improvement quarter-over-quarter.Key highlights include 32% gross margins and significant operational streamlining. The company announced a CFO transition, with Ricardo Rodriguez stepping down and Grant Thoele, current Chief of Staff to CEO, taking over. For H2 2025, Aspen projects revenue of $140-160 million and Adjusted EBITDA of $20-30 million, with expected improvements in profitability due to cost structure optimization.The company maintains a strong balance sheet with $167.6 million in cash and equivalents and plans to reduce capital expenditure requirements while pursuing strategic opportunities.

#ASPN Aspen Aerogels, Inc. Reports Second Quarter 2025 Financial Results and Recent Business Highlights

www.stocktitan.net/news/ASPN/aspen-aerogels...

Thiard News@F4F

@newsen.bsky.social

7 months ago

ASPN: Your Reliable Partner for Direct-to-Consumer Pharmacy Solutions ASPN stands at the forefront of direct-to-consumer pharmacy solutions, ready to assist manufacturers with rapid implementation. With proven infrastructure and flexible models, ASPN delivers results efficiently.

ASPN: Your Reliable Partner for Direct-to-Consumer Pharmacy Solutions #USA #Florham_Park #Asembia #ASPN #DTC_Pharmacy

Small Cap Strategist

@smcapstrategist.bsky.social

10 months ago

Small-cap stocks with strong volume declines, Thu May 8th - #ZGN #UHG #TLS #SBET #QNST #MFH #LILIAK #INGN #ERII #DCBO #FGTS #AXDX #CEIX #TLYS #SAR #LUCK #HIPO #ASPN #dCODI - More: crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

10 months ago

Aspen Aerogels, Inc. Reports First Quarter 2025 Financial Results and Recent Business Highlights Aspen Aerogels (NYSE: ASPN) reported its Q1 2025 financial results, showing revenue of $78.7 million, a 17% decrease from Q1 2024's $94.5 million. The company recorded a significant net loss of $301.2 million, largely due to a $286.6 million impairment charge related to demobilizing their planned Georgia manufacturing plant and $9.8 million in restructuring costs. Adjusted for these charges, net loss would be $4.8 million. The quarter showed mixed segment performance with Thermal Barrier revenue at $48.9 million (down 25% YoY) and Energy Industrial revenue at $29.8 million (up 3% YoY). The company secured a new PyroThin contract from a leading American OEM for an LFP vehicle platform. For Q2 2025, Aspen projects revenue between $70-80 million and adjusted EBITDA between breakeven and $7 million.

#ASPN Aspen Aerogels, Inc. Reports First Quarter 2025 Financial Results and Recent Business Highlights

www.stocktitan.net/news/ASPN/aspen-aerogels...

Christel Wekon-Kemeni, MD

@therealdrdub.bsky.social

10 months ago

Thank you for the opportunity to share a piece of my story with your audience!! Nothing will stop me from continuing to fulfill my purpose! 🙏🏿🔥 #ASNKidneyNews #ASPN #RepresentationMatters

InsiderFinance

@insiderfinance.com

11 months ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#IMUX, #MREO, #PSN, #SMG, #ASPN

#OptionFlow #OptionsTrading #Trading

StockTitan

@stocktitan.net

1 year ago

Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Business Highlights Aspen Aerogels (NYSE: ASPN) reported strong financial results for Q4 and FY 2024. The company achieved $452.7 million in FY 2024 revenue, a 90% year-over-year increase, with gross margins growing to 40%. Q4 revenue reached $123.1 million, up 46% YoY, including record Energy Industrial revenue of $53.1 million.The company reported net income of $13.4 million for FY 2024 (including a $27.5 million one-time charge) and Adjusted EBITDA of $89.9 million. Q4 delivered net income of $11.4 million and generated $20.9 million in free cash flow. The company ended 2024 with $220.9 million in cash.Aspen secured a new PyroThin® Thermal Barrier contract with Volvo Truck and announced plans to halt construction of its Statesboro plant, opting instead to maximize capacity at existing facilities. For Q1 2025, the company projects revenue between $75-95 million with Adjusted EBITDA ranging from breakeven to $15 million.

#ASPN Aspen Aerogels, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Business Highlights

www.stocktitan.net/news/ASPN/aspen-aerogels...

StockTitan

@stocktitan.net

1 year ago

Major Victory for Aspen Aerogels: Secures Patent Protection in European Insulation Market Aspen Aerogels reaches settlement with AMA in Italian court over aerogel insulation patent dispute, reinforcing its IP protection and market position in Europe.

#ASPN Aspen Aerogels Reaches Settlement with AMA to Resolve Patent Case

www.stocktitan.net/news/ASPN/aspen-aerogels...

@aspneph.bsky.social

1 year ago

Congratulations to the 2025 ASPN Awards winners! #ASPN #PediatricNephrology #Nephrologist #Pediatric #ASPNeph #Award

Alafair Biosciences, Inc.

@alafairbiosciences.bsky.social

1 year ago

A great time for @alafairbiosciences.bsky.social
at #AAHS #ASPN #ASRM in Hawaii! For more information, visit us at www.alafairbiosciences.com.

Duke Paired Undergraduate Mentoring Program in Uronephrology

@dukepump.bsky.social

1 year ago

Exciting news from Duke PUMP, addressing the uronephrology workforce crisis. @kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social @dukekidney.bsky.social #NIDDK #ASPN @rheaultm.bsky.social #simoneSanna-Cherchi @atomickidney.bsky.social @dukeopsd.bsky.social @dukectsi.bsky.social

@gbadegesinlab.bsky.social

1 year ago

Addressing the Workforce Crisis in Uronephrology: Design... : Clinical Journal of the American Society of Nephrology An abstract is unavailable.

Our initial observations in @dukepump.bsky.social a program addressing the workforce crisis in uronephrology. journals.lww.com/cjasn/fullte... Take home: program is feasible, student feelings of id as BioMed researcher up!! We are excited with these baby steps #NIDDK @asnkidney.bsky.social #ASPN 👏

Duke Paired Undergraduate Mentoring Program in Uronephrology

@dukepump.bsky.social

1 year ago

Please welcome Duke PUMP to Bluesky. This is a summer research program set up to address workforce crisis in uronephrology @dukeopsd.bsky.social @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social #NIDDK #ASPN @dukectsi.bsky.social

InsiderFinance

@insiderfinance.com

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MPC, #CMTL, #GERN, #ASPN, #RYN

#OptionFlow #OptionsTrading #Trading

@gbadegesinlab.bsky.social

1 year ago

Duke PUMP is our effort to address the workforce crisis in Nephrology& urology. We are accepting applications for our 3rd cohort. Only 37% of positions filled in Peds Neph this year!! We should engage young folks in career in Neph from elementary school!! #NIDDK #ASPN @asnkidney.bsky.social

#RKLB to $100 by 2026

@fellowhumanperson.bsky.social

1 year ago

Learn from my mistakes.

Investing can be risky. There’s no reason to invite unnecessary additional risks.

Aspen Aerogels #ASPN faced a challenging future if Trump was elected. I should not have continued to hold the stock in the run-up to the election.

@gbadegesinlab.bsky.social

1 year ago

Match day!! Huge workforce crisis in Peds Nephrology, only 20% of program filled second to the last overall. We need urgent intervention #ASPN #NIDDK #AAP #ASN @atomickidney.bsky.social @jostflynnmd.bsky.social @asouth-neph.bsky.social @kidneyomicsamps.bsky.social @rheaultm.bsky.social

#RKLB to $100 by 2026

@fellowhumanperson.bsky.social

1 year ago

On the other hand, I’m thankful that #ASPN *is* my smallest position.

@gbadegesinlab.bsky.social

1 year ago

rFSGS is a major cause of kidney tx loss. There is a need for multidisciplinary rethinking of how we are going to solve this. We are all looking forward to the Dec 9th meeting in DC @genetickidneydoc.bsky.social @isgd.bsky.social #ASPN @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social

Market Wire News

@marketwirenews.com

1 year ago

Just In: ( NYSE: #ASPN ) Why I Keep Buying These 14 Incredible Growth Stocks

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

News; ( NYSE: #ASPN ) Aspen Aerogels, Inc. Receives Conditional Commitment for Proposed DOE Loan and Provides Q3 2024 Preliminary Financial Results

#StockMarket #News

InsiderFinance

@insiderfinance.com

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#FSLY, #TUP, #CLOV, #ASPN, #ROKU

#OptionFlow #OptionsTrading #Trading